Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.


Journal

Blood cells, molecules & diseases
ISSN: 1096-0961
Titre abrégé: Blood Cells Mol Dis
Pays: United States
ID NLM: 9509932

Informations de publication

Date de publication:
09 2020
Historique:
received: 08 05 2020
accepted: 10 05 2020
pubmed: 2 6 2020
medline: 15 1 2021
entrez: 2 6 2020
Statut: ppublish

Résumé

Febrile neutropenia is a common cause in morbidity and mortality during treatment of hematological neoplasms. Subjects included all cases admitted under hematology department with febrile neutropenia from February to June 2018. Each febrile episode was investigated by standard investigations (Blood culture, Chest x ray etc.); Procalcitonin (PCT) and c reactive protein (CRP) was sent at fever onset 0, 24, 48 h, day 7 and day 14. Data was analyzed for 52 febrile episodes in 50 patients. PCT cut off value at 24 h of ≤1.2 ng/ml had a sensitivity and specificity of 62.5% and 87.5% for discriminating Invasive fungal infection (IFI) and Microbiologically documented infection (MDI) (p = 0.033). PCT had a negative predictive value of 70% for the diagnosis of IFI as compared to MDI. CRP cut off >160 mg/dl at 48 h was suggestive of fever due to fungal infection with a sensitivity of 100%, specificity of 48%, PPV of 33.3% and NPV of 100%. CRP at 24 and 48 h of fever was useful to distinguish non-infectious causes of fever from infectious causes. PCT at 24 h and CRP at 48 h was useful in identifying fungal infection. CRP was a better marker when compared to PCT for identifying disease fever.

Identifiants

pubmed: 32480243
pii: S1079-9796(20)30207-2
doi: 10.1016/j.bcmd.2020.102445
pii:
doi:

Substances chimiques

Biomarkers 0
Procalcitonin 0
C-Reactive Protein 9007-41-4

Types de publication

Comparative Study Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102445

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to disclose.

Auteurs

Rohan Halder (R)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India. Electronic address: rohanhalder86@gmail.com.

Tulika Seth (T)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Pradeep K Chaturvedi (PK)

Department of Reproductive Biology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Priyanka Mishra (P)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Manoranjan Mahapatra (M)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Hara P Pati (HP)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Seema Tyagi (S)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Renu Saxena (R)

Department of Hematology, All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH